Choong-wae to initiate phase 3 trial of avanafil for treatment of erectile dysfunction

Choong-wae Pharm said on November 13 that it will conduct phase 3 study of avanafil, its investigational new drug for the treatment of erectile dysfunction (ED) under the recent approval of the Korea Food and Drug Administration. Avanafil is a next-generation, fast-acting, selective, investigational oral phosphodiesterase type 5 (PDE5) inhibitor.

It is expected that this study will enroll ap...